Non-specific cellular uptake of surface-functionalized quantum dots by Kelf, T A et al.
1 
 
Non-specific cellular uptake of surface-functionalized 
quantum dots 
 
 
T A Kelf1, V K A Sreenivasan1, J Sun1, E J Kim2, E M Goldys1 and A V 
Zvyagin1 
1 MQ Photonics Centre, Faculty of Science, Macquarie University, Sydney, 
Australia 
2Department of Science Education-Chemical Education Major, Daegu 
University, Gyeonbuk, South Korea 
 
E-mail: azvyagin@science.mq.edu.au  
 
Abstract.  We report a systematic empirical study of nanoparticle internalization 
into cells via non-specific pathways.  The nanoparticles were comprised of 
commercial quantum dots (QDs) that were highly visible under a fluorescence 
confocal microscope.  Surface-modified QDs with basic biologically-significant 
moieties, e.g. carboxyl, amino, streptavidin were used, in combination with the 
surface derivatization with polyethylene glycol (PEG) in a range of immortalized 
cell lines.  Internalization rates were derived from image analysis and a detailed 
discussion about the effect of nanoparticle size, charge and surface groups is 
presented. We find that PEG-derivatization dramatically suppresses the non-
specific uptake while PEG-free carboxyl and amine functional groups promote 
QD internalization.  These uptake variations displayed a remarkable consistency 
across different cell types. The reported results are important for experiments 
concerned with cellular uptake of surface-functionalized nanomaterials, both 
when non-specific internalization is undesirable and also when it is intended for 
material to be internalized as efficiently as possible. 
 
PACS: 42.62.Be, 81.07.Ta, 87.16.dp, 87.85.Rs 
 
Introduction 
To sustain the lifecycle of living cells material must be absorbed from the extracellular medium 
via certain mechanisms.  These mechanisms fall into two categories: specific internalization, that 
requires the cell to actively recruit molecules into the cytoplasm, and non-specific internalization, 
which constitutes random processes in which the cell has no active control.  Receptor-mediated 
endocytosis is an important example of the specific uptake mechanism that facilitates import of 
selected extracellular macromolecules and allows inter-cellular signalling.  This process is 
regulated by plasma membrane receptors that are only activated by receptor-specific ligands [1-
4]. As a result, only biomolecular complexes grafted with these ligands can gain entry into the 
cell.  In the process of endocytosis the plasma membrane is engulfed inwards from specialized 
membrane micro-domains forming either clathrin- or caveolin-coated pits.  In recent years this 
specific cellular uptake mechanism has been a subject of intense research driven by the 
motivation to better understand cellular molecular trafficking and potential applications in 
targeted drug delivery [5].  Non-specific cellular uptake refers to a process of extraneous material 
internalization; it can vary depending on the cell type and has poor material selectivity.  For 
virtually all eukaryotic cells, non-specific uptake is dominated by pinocytosis [6, 7].  This 
process involves continual budding of vesicles from the cell surface, allowing fluid and extra-
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cellular material to enter the cell.  After either specific or non-specific internalization the material 
trapped in the vesicles is sequestered into endosomes, subsequently it is transported to locations 
within the cell [4], moved back to the extra-cellular medium, or taken to the lysosomes for acidic 
degradation.  Nanoparticles incubated with cells are eventually concentrated in lysosomes or in 
the perinuclear recycling compartment [8] as they are of no use to the cell.  Often, due to the 
similarity of pinocytosed and receptor-mediated internalization patterns, the discrimination of the 
non-specific versus specific uptake processes is not straightforward.  The literature reports 
addressing non-specific cellular uptake and the key factors determining its rate are dispersed over 
various research fields from gene transfection [9, 10] and drug delivery [11, 12] to nanoparticle 
synthesis [13, 14].  They provide evidence that the key factors determining internalization are 
size [15, 16, 17], charge [18, 19] and surface functional groups [12], where polyethylene glycol 
(PEG) is of particular importance [20-22]. 
 
Nanoparticles serving as biomolecular cargo vehicles hold considerable promise for targeted 
delivery, with their large surface areas hosting various functional moieties that can dock different 
biomolecules.  Quantum dots (QDs) have been intensely investigated due to their exceptional 
luminescent properties: unprecedented efficiency (high action cross-section, which is a product of 
quantum efficiency and absorption cross-section [23]).  Spectral emission tunability by size 
variations allowing spectral multiplexing and their convenient excitation band in the UV spectral 
range make QDs particularly attractive as fluorescent labels and they have already been widely 
used in a number of biological studies, as molecular reporters [24].  Their large two-photon 
action cross-sections compared to the best organic fluorophores add further to their appeal [23].  
The QD technology is maturing rapidly with a range of QD products available commercially, 
including QDs with amino, carboxyl and streptavidin surface groups.  The toxicity of QDs 
remains a hotly debated issue, which may limit medical applications [25-28], however their 
brightness and photostability make them ideal for in-vitro biomedical applications. 
 
In this paper, we investigate the cellular internalization rates of a range of different commercially 
available QDs including streptavidin-coated QDs and carboxyl- and amino- surface 
functionalized QDs with and without PEG linker chains.  Carboxy- and amino- functionalised 
QDs have been chosen because they are readily amenable to further conjugation with 
biomolecules following various chemical treatments. Streptavidin-coated QD are important 
because, by virtue of the exceptional affinity of streptavidin for biotin (dissociation constant ~ 10-
15 M), streptavidin QDs can be easily attached to biomolecules of interest 
(ligands/proteins/antibodies), which have been coupled to biotin.  Some of the QDs investigated 
here were also modified chemically to further understand the effect of chemical groups on 
cellular internalisation dynamics. This modification revealed significant modulation of the 
cellular uptake rates. 
The aim of this paper is to provide an initial guide for the use of nanoparticles in cellular systems.  
While this work focuses specifically on QDs, the results and discussion can be applied to various 
other types of nanoparticles as the effects of size, surface charge and molecular coatings are 
generally more important than the chemical identity of nanoparticles.  This general discussion 
aims to shed light in issues arising in early stages of the research on application of nanoparticles 
in cellular systems. Our experience suggests that without proper controls and time-consuming 
investigations the reasons for particle internalization can be hard to elucidate. 
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Experimental Procedure 
 
1. Quantum Dots 
All QDs used in this study were obtained from two major suppliers: Invitrogen (Oregon, USA), 
(referred to as QDi) and eBiosciences (San Diego, USA), (referred to as QDe). Both have the 
same basic nanostructure consisting of a cadmium selenide core passivated with a layer of zinc 
sulphide (CdSe/ZnS). For this study, QDs with a fluorescence emission maximum at 605 nm 
were chosen; the QD excitation band is broad, mostly in the ultraviolet spectral range, and has an 
additional excitation peak at 545 nm allowing convenient excitation in visible.  All QDs are 
capped with an amphiphilic polymer coating by the manufacturer. This coating serves three 
purposes: to reduce cytotoxicity, improve colloidal stability, and enable the grafting of functional 
moieties. Hence, the overall size of these QD complexes ranged from 15 nm to 25 nm depending 
on the surface functional groups. This work used seven different types of QDs whose full list is 
shown in figure 1. They were, as follows: Carboxyl-QDs (referred to as C-QDi), Amino-PEG 
QDs (N-pQDi, where p refers to the presence of polyethylene-glycol, PEG) and Streptavidin-QDs 
(SA-QDi), all purchased from Invitrogen.  Carboxyl-PEG QDs (C-pQDe) and Amino-PEG QDs 
(N-pQDe), were purchased from eBiosciences.  To further understand the effect of the surface 
terminal groups, C-QDi and C-pQDe were conjugated to ethylene-diamine to obtain amine-
terminated quantum dots, referred to as N-CC-QDi and N-CC-pQDe.  The QDs can be divided 
into PEG-derivatized and PEG-free, these are drawn in the left and the right column in figure 1, 
respectively.  It is also possible to classify the QDs with respect to the chemical terminal group 
(amine, carboxyl or streptavidin), some of which have a reacted variant. 
 
For the coupling reaction 400 fmole (1 molar equivalent) of QDs were diluted in 400 µL (MES) 
buffer with 2 mM (EDTA, pH=6) in a vial. Freshly dissolved room temperature equilibrated 1-
ethyl-3-(3-dimethylaminopropyl) carbodiimide (EDC) (10 mg/mL) and sulfo- N-
Hydroxysuccinimide (sulfo-NHS) (20 mg/mL) solutions in deionized water were added to the 
QD vial for activation and the solution was incubated at room temperature with gentle shaking 
for 15 minutes.  An excess of ethylene-diamine was added along with 50 µL of 5x borate buffer 
(pH = 8.4). After 1-hour room temperature incubation with gentle shaking free EDC, sulfo-NHS 
and ethylene-diamine were removed by using a desalting column (Prepacked Sephadex G-25 
medium column, GE Healthcare) equilibrated with phosphate buffer saline PBS (pH = 7.2).  
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Figure 1. List of commercially available QDs from Invitrogen and eBiosciences.  Chemical 
structure of the surface groups is shown along with the short hand notation.  Additional chemical 
reactions have been performed where noted. 
 
the concentration and quantum efficiency of the reacted QDs were measured using an absorption 
spectrometer and fluorimeter, by comparing with untreated QDs.  We found that Invitrogen QDs 
have approximately 2.5 times greater quantum efficiency than that of the eBiosciences QDs.  
After the EDC reaction the Invitrogen QDs (N-CC-QDi) and eBiosciences QDs (N-CC-pQDe) 
suffered a 2.5- and 10- fold drop in quantum efficiency, respectively. 
 
2. Cell Experiments 
Two rat tumour cell lines were obtained from ATCC (USA), these were GH4C1 (pituitary) and 
AR42J (pancreas) cells.  A pituitary tumour cell line, AtT20 was a kind gift from Dr M Connor 
(The University of Sydney, Australia).  Ar42J cells were cultured in F-12K medium (DKSH) 
with 20% fetal bovine serum.  Both GH4C1 and AtT20 cells were cultured in F-10 Ham’s 
(DKSH) with 2.5% fetal bovine serum and 15% horse serum.  All cells were grown in culture 
flasks (BD Falcon) inside a humidified incubator at 37oC with 5% CO2. 
 
The day before experiments cells were transferred to 8 chambered culture slides (BD Falcon) and 
incubated in medium, as above.  The cells were then incubated with a 20-nM QD solution in 300-
μL phosphate buffer saline (PBS, Invitrogen, pH = 7.2) with additional CaCl2 (0.9 mM), MgCl2 
(0.5 mM), BSA (0.1%) and D-Glucose (20 mM) at 37oC, 5% CO2 for 60 min.  After QD 
incubation, cells were washed twice with PBS then fixed using 3.7% (w/v) paraformaldehyde 
solution for 20 min followed by a final PBS wash. 
 
3.  Imaging and image processing 
A confocal laser-scanning microscope (Leica TCM SP2) with a 488-nm Ar-ion laser was used for 
acquisition of fluorescence images of the QDs. An external Nikon DS-Qi1Mc camera was 
attached to acquire the respective bright field, transmission images. The internalization was 
quantified by fluorescence intensity of the QDs inside the cells.  For each experiment, 
approximately 20 cells were imaged using a spectral filter of the bandwidth 585 nm – 625 nm to 
accommodate for the QD emission and reject illumination light.  All imaging parameters were 
kept constant for all experiments to allow direct comparisons.  After background correction and 
intensity scaling to account for different QD quantum efficiencies, the total brightness inside each 
cell was calculated (software Igor Pro, Wavemeterics).  These values were normalized to the cell 
size and averaged over all cells to provide a single number that corresponded to the level of 
internalization for each QD type into each cell line.  These values were subsequently normalized 
to the internalization rate of N-CC-QDi into AtT20 cells to facilitate comparison between 
different cell lines and QD types. 
 
Results and Discussion 
 
Results 
Firstly, we examined the internalization mechanism of QDs.  Figure 2a shows representative 
images of 20 nM of C-QDi incubated with Ar42J cells for one hour at 4oC and 37oC.  No 
internalization was observed at 4oC, with the QDs localized on the cell membrane.  The cellular 
machinery was switched on at 37ºC manifested by the QD uptake in the cellular cytoplasm at the 
expense of the reduced concentration of QDs localized on the membrane.  This internalization 
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mechanism was active, as opposed to, for example, the passive diffusion cellular uptake of small-
size molecules [29]. This observation is consistent with receptor-mediated endocytosis [30] that 
is not effective at 4ºC.  The receptor-mediated endocytosis mechanism of the QD uptake was 
additionally confirmed by pre-treatment of the Ar42J cells with sucrose before the incubation of 
20 nM of C-QDi, with the result shown in figure 2b.  In this case, no internalization was 
observed.  Sucrose is known to disrupt the formation of clathrin vesicles [16, 31], hence this 
shows that C-QDi were predominantly internalized via endocytosis that involved clathrin-coated 
vesicles.  Figure 2c shows the detected level of C-QDi in Ar42J cells as a function of incubation 
time. The internalization rates were calculated by analysing the number of QDs inside the cells 
(ignoring those localized on the membrane), and averaging over 20 cells for each time point.  The 
internalization saturated at approximately 10 minutes, a period limited by the number and activity 
of the receptors recruited for the internalization process. The variation in the internalization level 
at longer incubation times is explained by statistical variations in the cell uptake. We verified that 
there was no observable variation in the internalization rate up to 90 minutes. The incubation 
time of 60 minutes was used in further experiments to ensure that the internalization of the 
nanoparticles was as complete as possible. 
 
 
 
Figure 2.  (a) C-QDi incubated at 4oC and 37oC in Ar42J cells, QDs are pseudo-colour-coded in 
red, nuclei were stained with blue fluorescent dye Hoerst and shown in blue colour.  Image size 
37.5 µm × 37.5 µm.  (b) C-QDi incubated (i) with sucrose and (ii) without sucrose in Ar42J cells. 
Image size and colours are the same as in (a).  (c) plot of the C-QDi internalization into Ar42J 
cells versus incubation time. 
 
 
Figure 3 shows representative images of different QDs in the tested cell lines.  Figure 4 shows 
their calculated internalization levels, with the values summarized in table 1.  QD sizes and zeta 
potentials, measured using a dynamic light scattering (DLS) method (Zetasizer, Malvern, UK) 
are also presented in table 1.  QD hydrodynamic diameters (which overestimate the geometric 
average diameter by roughly 10%) were measured to be approximately 20 nm with the exception 
of N-CC-QDi (100 nm, table 1).  This larger measured size reflects the process of QD 
aggregation in the buffer solution.  We have tested all QD solutions in water and PBS a number 
of times and have sometimes found aggregates present in the data.  The use of PEG and the 
amphiphilic polymer coating act to reduce aggregation significantly over that of bare particles but 
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never completely remove the effect.  Hence, sizes of the nanoparticle complexes formed in buffer 
medium, rather than their primary sizes, should be taken into account in the context of cellular 
internalization.  The effect of nanoparticle size will be discussed later; however we note that QD 
aggregates were under 200 nm in size, with smaller aggregate/primary particle often present in 
buffers.  Such aggregation levels still permitted the efficient QD uptake into the cells, as shown 
in figure 3 for N-CC-QDi since the vesicles can accommodate up particles up to ~ 200 nm. 
 
We now discuss the general trends that can be seen in the data.  On average, Ar42J and GH4C1 
cells had a similar level of internalization, which was, roughly, half that of AtT20 cells.  QDs 
surface-derivatized with PEG showed comparatively low levels of cellular internalization.  We 
note internalization of N-pQDi was virtually negligible, at the noise level of the detection.  The 
level of the SA-QDi internalization was slightly greater than that of most of the PEG-derivatized 
QDs, except for AtT20 where low internalization rate is observed. 
 
 
 
Figure 3. Representative bright-field images of the tumour cells superimposed with the 
epifluorescence images of quantum dot fluorescence (red).  The image acquisition parameters 
were constant for all experiments to facilitate direct comparison.  Each image panel size 37.5 µm 
× 37.5 µm. 
7 
 
 
 
Figure. 4. Bar plot of the QD uptake levels for the three tumour cell lines: (a) normalized to that 
of N-CC-QDi quantum dots in AtT20 cells; (b) normalized across each cell line data to that of N-
CC-QDi. 
 
Table1.  Normalized QD uptake rates into the 3 tumour cell lines, QD size and zeta potential. 
QD Type 
Internalization 
 
Size 
(nm) 
Zeta Potential 
(mV) Ar42J GH4C1 AtT20 
N-CC-QDi 0.225 0.419 1  100 -32 
C-QDi 0.12 - 0.082  28 -31 
N-pQDe 0.03 0.027 0.078  23 -2 
N-CC-
pQDe 
0.024 0.035 0.022   24 -12 
C-pQDe 0.029 0.002 0.018  22 -12 
SA-QDi 0.039 0.043 0.012  20 -15 
N-pQDi 0.005 0.008 0.002   21 -2 
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Discussion 
It is well known that a number of factors affect the rate of non-specific particle internalization 
into cells.  These include charge [18, 19], size [15, 16, 17], and surface functional groups [12].  
Additionally, hydrophobic nanomaterials which have an affinity to the lipid bilayer of the cell 
facilitate uptake [32].  Pristine amphiphilic-polymer-coated QDs and PEG-derivatized QDs have 
similar hydrophilic properties, and yet as shown, their cellular uptakes are dramatically different.  
To understand this difference we will discuss the roles of the receptor-specific mediated pathway, 
size effects, PEG-derivatization, and charge, in the internalization process. 
 
Firstly, we discuss whether direct receptor mediated pathways plays a significant role in the 
internalization of the streptavidin-coated QDs in comparison with non-specific mechanisms.  
Streptavidin has a high binding affinity to biotin, which belongs to the class of vitamins.  Since 
biotin is present in the culture medium and can be adsorbed onto the cell membrane this could 
enhance the internalization of Sav-QDi through streptavidin biotin binding [33].  Also, it has been 
reported that the RYD peptide chain in streptavidin is sufficiently similar to the sequence RGD 
that is used by many cell adhesion-related molecules, and, thus, unmodified streptavidin can be 
directly internalized [34].  Thirdly, there can be non-specific internalization through pinocytosis, 
a common pathway for a broad class of extraneous material internalisation, including QDs.  We 
tested the first pathway by pre-binding biotin to the streptavidin-coated QDs, and found no 
discernable change in the level of internalization. This ruled out the possibility of internalization 
via the biotin-mediated pathway.  The second pathway was more difficult to test, however the 
total observed internalization levels of the streptavidin-coated QDs were broadly comparable to 
the lowest levels of internalization of the other (PEG-containing) QDs, that were limited to the 
pinocytosis pathway.  This suggests that pinocytosis was the dominant mechanism.  The added 
complexity of the potential multiple internalization pathways makes streptavidin-coated QDs less 
attractive, as a reference nanoparticle unless preliminary work is conducted to ensure the 
receptor-mediated internalization is significantly greater compared to alternative processes.  
 
With respect to the carboxyl group mediated internalization, it has been shown that carboxylic 
QDs were endocytosed via lipid rafts [35].  However, since the sucrose-induced inhibition of the 
C-QDi internalization strongly suggested the clathrin-vesicle pathway (figure 2b), the lipid raft 
internalization mechanism is ruled out as a dominant factor for these cell lines.  At the same time, 
its active role in the reported internalization scenarios [35] indicates that the process can be more 
complex and makes it difficult to explain C-QDi internalization within a simple framework. 
 
 
Size has been shown to have a strong influence over the rate of nanoparticle internalization.  
Whilst our primary QDs were of a similar size, it was noted that there can be aggregation in the 
culture medium, leading to distribution of actual sizes.  The effect of size on internalisation has 
been addressed in several papers [16, 17, 37-39], and although consensus has not been reached, a 
general trend is emerging, as schematically shown in Figure 5.  The size effects fall 
approximately into three classes: Clathrin, Caveolae, Macro pinocytosis. 
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Figure 5. Qualitative plot of the internalization level versus the particle size.  This plot was 
compiled using published data [16, 17, 37-39] obtained for a variety of cell models and particle 
types. 
 
 
Clathrin-mediated endocytosis pathways are predominant for nanoparticles smaller than 200 nm, 
and it has been shown both experimentally [16] and theoretically [38] that 50 nm particles are 
most efficiently endocytosed.  The non-specific internalization in this size range is hypothesized 
to occur via adsorption of the proteins from the culture medium onto the particles surface, 
followed by their internalization via receptor-mediated pathways.  Thus the rate of internalization 
is dependent on the available receptors on the cell surface and the number of receptors a single 
nanoparticle triggers when it adheres to the membrane.  It has been shown experimentally that for 
particles <50 nm, several closely spaced particles are required to trigger the formation of a 
clathrin-coated vesicle [17].  As a result, an internalization rate per particle is reduced, as 
manifested by a descending slope at sizes below 50 nm.  A theoretical model based on the 
balance between free energy required to drive nanoparticles into the cell and diffusion kinetics of 
the recruitment of receptors to the binding site [38] helps explain this decreasing internalization 
level.  For particle sizes in excess of 50 nm, more receptors are engaged by the particle 
internalization process followed by their translocation into the cytoplasm.  To sustain the 
internalization, these receptors must be recycled back to the membrane, which takes time and 
limits the internalization rate.  When nanoparticles reach sizes greater than 200 nm they can no 
longer be internalized through clathrin vesicles, and cells recruit alternative internalization 
pathways.  It has been shown [17] that caveolae-mediated pathways were of the greatest 
importance for particles between 200 nm and 1000 nm.  This process is slower than that of the 
clathrin internalization, hence the efficiency is lower.  For particles greater than a micron in size 
(up to 5 µm in diameter), the effect of macro-pinocytosis becomes important.  This requires 
ruffling of the cell membrane to form large troughs, which can subsequently bud in the form of 
large size vesicles into the cell.  This is a genuinely non-specific process, and highly dependent of 
cell type and internalization conditions.  The internalization rate drops dramatically above around 
one micron due to difficulty of forming these large vesicles. 
Particle shape has also been shown to play a role in the internalization [37], which adds another 
layer of complexity.  We note briefly that a cell perceives the particle in terms of its surface area 
in contact with the cell membrane, and thus this size governs internalization, as discussed above. 
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We now turn to the role of PEG in the non-specific nanoparticle uptake in cells. While precise 
reasons behind the significantly reduced internalization of PEG-derivatized nanoparticles are still 
debated, a number of consistent observations have been presented in the literature [12, 32, 35, 
36].  PEG is an uncharged, hydrophilic polymer, which is non-immunogenic and characterized by 
a high steric stabilization.  Figure 6 shows the zeta potential of the investigated QDs in PBS (pH 
= 7.2), along with the average internalization rate over the investigated cell lines. 
 
 
 
Figure 6.  Plot of the QD zeta potentials in PBS, pH 7.2, and average internalization levels. 
 
As can be seen, PEG-derivatized QDs had zeta potentials closer to zero than their pristine 
counterparts.  This surface charge neutralization occurs due as the PEG molecules stopping the 
liquid flow in their vicinity. The fluid slippage plane was, therefore, shifted, and, as a result, 
modified the zeta potential (the zeta potential is defined the electrostatic potential measured at the 
slippage plane – the further the slippage plane from the particle surface, the smaller the potential, 
and hence, the zeta-potential ) [14, 18].  This effect is influenced by both PEG chain length, and 
the density of PEG molecules on the nanoparticle surface.  To test this dependency, we 
performed EDC reactions to conjugate two different length PEG molecules (molecular weight 
3400 and 5000 Da) in different surface concentrations to C-QDi, as shown in figure 7. 
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Figure 7.  Zeta-potential of QDs derivatized by 3400-Da and 5000-Da PEG molecules at 
different surface densities. 
 
We calculated that up to 400 PEG molecules can covalently bind to an individual QD.  At this 
PEG surface density the measured zeta potential was close to zero, showing almost complete 
screening of the QD surface charge.  A PEG layer thickness of 2 nm was inferred from the 
hydrodynamic diameter measured by DLS.  As the surface density was reduced, the surface 
became more highly charged (the zeta potential shifted to the negative), approaching the value for 
the uncoated C-QDi.  The PEG surface density was correspondingly reduced, as confirmed by the 
DLS measurements.  Note that 3400-Da and 5000-Da PEG-derivatization showed similar result 
within the experimental accuracy, in agreement with the literature reporting the effect of PEG-
derivatization on the internalization at the 660-Da molecular weight [12]. 
A balance between the PEG length and surface density is important for optimal design of 
nanoparticle PEG-coating.  When densely packed, PEG covers the majority of surface binding 
sites, and the molecules align perpendicular to the particles surface. At a lower density, due to the 
flexibility of PEG, it conforms to a ‘mushroom’ type state, where the chains are bent over the 
surface, again covering a large number of surface sites [18].  The main difference between the 
two conformational states is that at the lower density, the PEG chains tangle and cause the 
terminal groups to become covered with the PEG layer.  As a result, non-specific internalisation 
[32, 41] is reduced.  By the same token, a number of bioconjugation-active terminals are also 
reduced.  While only limited information about the precise nature of the different QDs has been 
provided by the manufacturers, a different PEG length and density ratio is likely to account for 
the difference in internalization between N-pQDi and N-pQDe. 
It has been shown that charge has a profound effect on the rate of non-specific internalization [9, 
40], through electrostatic interactions.  The PEG molecules reduce the ability of the QD to 
undergo these interactions by physically separating the surface from that of the cell (steric 
hindrance), hence reducing QDs adherence to the cell membrane [13, 22, 41], and leading to 
reduced internalization.  PEG also acts efficiently to reduce protein adsorption onto the 
nanoparticle surface [12].  This property has been shown prevent phagocytosis [11, 12],  as well 
as  reducing the binding of nanoparticles to the cell membrane, and hence lowering 
internalization [16]. 
 
We now discuss the surface charge effect. The importance of surface charge on the non-specific 
internalization rate has been discussed in the past [12, 18, 19], and it has been shown that both 
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positively and negatively charged molecules can be efficiently internalized into cell, utilizing 
interactions with various charged proteins on the cell membrane [9, 10, 40].  It has also been 
shown that nearly neutral QDs with hydroxyl (-OH) surface functionalization, also exhibit greatly 
reduced non-specific internalization [13], when compared with the carboxyl or amino 
counterparts, so charge is of a definitive importance to understand the internalization 
characteristics. 
As noted above, presence of the PEG-layer reduces an effective number of the terminal groups 
due to the entanglement of the chains, and hence it reduces the apparent charge. The zeta-
potential measurements showed that PEG-derivatized QDs with amino terminal groups, while 
still negative, were charged more positively in comparison with those of the carboxyl groups, as 
expected.  This negative charge is attributed to the intrinsic zeta-potential of the pristine QDs. 
This was confirmed by the measurements of the PEG-free QDs, which both showed large 
negative zeta-potentials regardless of the terminal groups. 
 
Positively charged amino-functionalized particles exhibit the greatest internalization rates [10, 
42], that can be ten-fold higher than negatively-charged carboxylated particles in neutral pH [40].  
This is in agreement with our results, where both N-CC-QDi and C-QDi were internalized to a 
greater extent than SA-QDi and amino-functionalized particle internalization rate was, on 
average, ten-fold that of their carboxyl equivalents.  It should be noted that the overall charge of 
the QD will influence electrostatic interactions with the cell membrane, although molecular 
interactions with individual proteins become important in close proximity. We propose that that 
this is the reason that N-CC-QDi internalization exceeds that of the C-QDi, while the zeta 
potential is similar. 
 
Summary 
The level of cellular internalization of various commercially available QDs by three different 
tumour cell lines has been investigated.  Overall, we showed that the presence of PEG on the 
particle surface significantly reduced the internalization.  This was due to the PEG-layer-induced 
steric hindrance: the direct docking of QDs to the cellular membrane was obstructed, as well as 
protein adsorption on the QD surface, which otherwise would promote internalization.  Charge 
has the greatest effect on internalization level, so should be most carefully considered when 
conducting culture experiments in live cells.  While the uptake mechanisms of nanoparticles into 
cells is defined as non-specific, these pathways were initiated by surface receptors, either through 
direct interactions between the charged particle and the receptor or via proteins adsorbed on the 
nanoparticles surface.  
 
Commercially available, PEG-derivatized QDs are appropriate as control particles due to their 
low non-specific binding/internalization into the investigated cell types, of these we find N-pQDi 
to be best, showing almost zero levels of internalization.  Amino or carboxyl, PEG-free QDs can 
be absorbed by the cells in relatively large quantities due to their large surface charges, and while 
both positive and negatively charged particles are effectively internalized, positive amino capped 
particles are the most efficient.  Such particles can serve as useful staining models, or for toxicity 
evaluation, where pathway-specific trafficking into the cell is of little importance.  The 
importance of particle size should also be carefully considered, particles of the order of 50 nm 
will be most efficiently internalized into the cell, but this must be balanced with need of the 
particle once internalized, for protein pathway tracking for example, this size will affect the 
proteins movements in the cell. 
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This paper highlights that non-specific uptake is an important factor, when considering the use of 
nanoparticles in cellular systems.  We believe that these observations will be of use to researchers 
moving from the fields of physics and nanotechnology into cell biology in providing the basis 
needed to perform efficient studies into nanoparticle internalization and interactions with cellular 
systems. 
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